Search Within

Erel Joffe

Formats
  1. Meeting Abstract (56)
  2. Journal Article (24)
  3. Research Letter (3)
  4. Review (2)
Groups
  1. Department of Medicine (85)
  2. Hematologic Malignancies, Division of (85)
  3. Sloan Kettering Institute Postdocs (85)
  4. Survivorship Research (57)
  5. Center for Hematologic Malignancies (51)
  6. Lymphoma (50)

More Groups

People
  1. Andrew Zelenetz (47)
  2. Ariela Noy (42)
  3. Maria Palomba (42)
  4. Matthew Matasar (39)
  5. Paul Hamlin (37)
  6. Anita Kumar (36)

More People

Years
  1. 2024 (6)
  2. 2023 (9)
  3. 2022 (14)
  4. 2021 (22)
  5. 2020 (18)
  6. 2019 (13)

More Years

Publications
  1. Blood (31)
  2. Hematological Oncology (10)
  3. Journal of Clinical Oncology (9)
  4. Blood Advances (6)
  5. Blood Cancer Journal (4)
  6. International Journal of Radiation Oncology, Biology, Physics (3)

More Publications

Publishers
  1. American Society of Hematology (37)
  2. Wiley Blackwell (10)
  3. American Society of Clinical Oncology (9)
  4. Elsevier Inc. (9)
  5. Nature Publishing Group (5)
  6. Taylor & Francis Group (3)

More Publishers

Results (85)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical characteristics and outcomes of extranodal stage I diffuse large B-cell lymphoma in the rituximab era
    Journal Article

    Bobillo, S.; Joffe, E.; Lavery, J. A.; Sermer, D.; Ghione, P.; Noy, A.; Caron, P. C.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • Favorable outcomes among patients with T-cell/histiocyte-rich large B-cell lymphoma treated with higher-intensity therapy in the rituximab era
    Meeting Abstract

    Robin, E. T.; Drill, E.; Batlevi, C. L.; Caron, P.; Falchi, L.; Hamilton, A.; Hamlin, P. A.; Horwitz, S. M.; Intlekofer, A. M.; Joffe, E.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • A multi-center, dose-finding study to assess safety, tolerability, pharmacokinetics and preliminary efficacy of a novel IRAK4 inhibitor CA-4948 in combination with ibrutinib, in patients with relapsed or refractory hematologic malignancies
    Meeting Abstract

    Nowakowski, G. S.; Leslie, L. A.; Joffe, E.; Rosenthal, A. C.; Lunning, M. A.; Patel, K.; Mead, M.; Landsburg, D. J.; Fenske, T. S.; Ramchandren, R.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • R-CHOP versus R-Bendamustine with or without rituximab maintenance in newly diagnosed follicular lymphoma patients with high SUV at baseline PET
    Meeting Abstract

    Mondello, P.; Strati, P.; Merryman, R. W.; Joffe, E.; Ruella, M.; Seshan, V.; St Pierre, F.; Major, A.; Pophali, P.; Fiasconaro, M.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Phase II study of pembrolizumab plus GVD as second-line therapy for relapsed or refractory classical Hodgkin lymphoma
    Meeting Abstract

    Moskowitz, A. J.; Shah, G.; Schòˆder, H.; Ganesan, N.; Hancock, H.; Davey, T.; Sohail, S.; Santarosa, A.; Pomerantz, L.; Jarjies, C.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Interim analysis from a prospective multicenter study of next-generation sequencing minimal residual disease assessment and CT monitoring for surveillance after frontline treatment in diffuse large B-cell lymphoma
    Meeting Abstract

    Kumar, A.; Westin, J.; Schuster, S. J.; Nowakowski, G. S.; Lossos, I. S.; Batlevi, C. L.; Caron, P.; Drullinsky, P.; Gerecitano, J.; Hamilton, A.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • CD5-positive marginal zone lymphoma: Clinical characteristics of the MSKCC Cohort, and comparison with the CD5-negative population
    Meeting Abstract

    Ghione, P.; Bantilan, K. S.; Joffe, E.; Lia Palomba, M.; Noy, A.; Matasar, M. J.; Caron, P.; Hamilton, A.; Hamlin, P. A.; Kumar, A.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Impact of interim PET on Hodgkin lymphoma treatment outcome and survival in clinical practice
    Meeting Abstract

    Zheng, S.; Gupta, K.; Goyal, P.; Nakajima, R.; Michaud, L.; Batlevi, C. L.; Hamlin, P. A.; Horwitz, S. M.; Kumar, A.; Matasar, M. J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Automated identification of lymphoma involving the bone from PET/CT reports using natural language processing and adaptive learning
    Meeting Abstract

    Navitski, A.; Goyal, P.; Ahsanuddin, S.; Zheng, S.; Joffe, E.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • A phase I and randomized phase II etctn study of KW-0761 (Mogamulizumab) and MK-3475 (Pembrolizumab) in relapsed and refractory diffuse large B-cell lymphoma
    Meeting Abstract

    Joffe, E.; Vardhana, S. A.; Kumar, A.; Abedi, M.; Hoeg, R.; Sharon, E.; Younes, A.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save